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To investigate the biochemical basis of the HIV-l resistance to AZT we obtained the RT mutant containing four amino actd substitutions by an 
oligonucleotide-directed mutagenesis technique. Enzymatic properties of the weld type and mutant RTs were compared. ‘AZT-resistant’ mutations 
in RT were shown to be associated with the reduced capability of AZT-TP to block the DNA- but not RNA-directed DNA synthesis. 
HIV-l; Reverse transcrtptase; ‘AZT-resistant’ mutation 
1. INTRODUCTION 2. MATERIALS AND METHODS 
AZT is the only drug routinely available for AIDS 
and advanced AIDS-related complex (ARC) therapy 
[1,2]. The 5’-triphosphate of AZT presumably inhibits 
HIV replication through the termination of nascent 
DNA chains synthesized by HIV reverse transcriptase 
[3,4]. However, HIV isolates from patients who were 
treated with AZT for more than 6 months show reduced 
sensitivity to this drug [5]. Sequence analysis of such 
HIV isolates demonstrated the presence of several com- 
mon mutations in the region coding for RT, which con- 
fer them a resistance to AZT. Amino-acid substitutions 
D67 + N, K70 4 R, T21.5 + F(Y) and (in most cases) 
K219 + Q were found in RT from the AZT-resistant 
HIV isolates [6]. Kinetic analysis and primer extension 
experiments did not reveal significant distinctions be- 
tween the w.t. and mutant RTs [6]. In this paper we 
demonstrate that ‘AZT-resistant’ mutations in RT are 
associated with the reduced capability of AZT-TP to 
block the DNA-directed DNA synthesis. 
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Abbrevtations. HIV-l, human immunodeficiency virus-l; RT. reverse 
transcriptase; CM, ‘complete’ mutant, contaming four amino acid 
substitutions; AZT, AZT-MP and AZT-TP, 3’-azido-2’,3’-di- 
deoxythymidine and its S-mono- and triphosphate; RNAtp. RNA 
template-primer; DNAtp- 1, DNA template-primer 1. DNAtp-2, 
DNA template-primer 2; w.t., wild type. 
HIV-1 RT was purified from E coli BL21 (DE3) cells [7] harboring 
the expression plasmid pBRP-5. The latter was obtained by placing 
the HIV-l RT gene under the control of T7 RNA polymerase pro- 
moter m the PET-3a plasmid. ‘AZT-resistant’ ‘complete’ mutant 
(D67 --f N, K70 --f R, T215 --f F, K219 + Q) was generated by an 
oligonucleotide-directed mutagenesis technique according to Kunkel 
et al [8]. The mutations were verified by dideoxy-sequencing [9]. (The 
detailed description of pBRT-5 construction and mutagenesis will be 
published elsewhere.) AZT-TP was the gift of Dr. M.K. Kukhanova 
(Institute of Molecular Biology, Moscow). Oligonucleotides were syn- 
thesized by the phosphotriester method. Poly(rA), oligo(dT),, and 
dNTPs were purchased from Boehringer Mannheim. “P-labeled 
dNTPs were obtained from the Physico-Energetical Institute 
(Obninsk. Russia). 
Heteropolymer RNA and DNA template-primers were obtained as 
follows. The 120 bp SaIGI-SphI fragment of pBR322 was cloned into 
pTZ-18/19 vectors to give the pPV-18 and pPV-19 plasmids, respec- 
tively. Smgle-stranded DNA was isolated from pPV-l&harboring E. 
coil cells according to [lo] and annealed with a 20 bases-long 
synthetic deoxyribooligonucleotide primer 5’-GCTCTCCCTTAT- 
GCGACTCC-3’ to give a DNAtp-1. To obtain RNAtp, RNA synthe- 
sized by a run-off transcription [l 1] of WGI-digested pPV-19 plasmid 
with T7 RNA polymerase was annealed with the same prtmer. To get 
DNAtp-2, the reverse sequence primer was annealed to the same single 
stranded DNA 
RT was assayed under standard conditions (37°C. 20 min) [12] in 
20 ~1 samples containing 50 mM Tris-HCl (pH 7.8), 10 mM MgCIZ. 
100 mM KCl, 1 mM DTT, 5% glycerol, 0.01% Nomdet NP40,50-100 
ng of enzyme, a templateeprimer complex at an appropriate concen- 
tration, and dTTP (in the case of poly(rA) ohgo(d or a mixture 
of four dNTPs (m the case of heteropolymer template). Kmetic para- 
meters were calculated using ENZFITTER program (Elsevier Bio- 
soft). 
5’-“P-end labeled primer was used m electrophoretic experiments. 
Standard reactions (see above) were stopped by adding a formamide 
dye [9], boiled for 5 mm and loaded onto 12% polyacrylamidee7 M 
urea gels. The fidelity of DNA synthesis was tested m the same reac- 
tion mixtures in the absence of one of the four dNTPs [13]. The 
processivity of the DNA synthesis was examined using the salmon 
sperm DNA as a trap according to [14]. 
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Table 1 
K,,, &M) and V,,, &mol/min mg of protein) values for dTTP of the w.t. and CM reverse transcriptases 
RT Template-primer 
July 1993 
Poly(rA) dT,, RNAtp DNAtp-1 
w.t. 3.1 k 0.6 12.0 * 3.1 0.4 f 0.1 1.7 f 0.3 1 .o IL 0.2 3.4 k 0 6 
CM 2.9 f 0.5 1.8 k 0.5 0 2 ? 0.05 0.7 + 0.2 0.7 + 0.1 2.1 f 0.5 
The saturating concentrattons of templates and 30 PM concentrations of dNTPs other than dTTP were used 
3. RESULTS AND DISCUSSION 
Though the association between the distinct muta- 
tions in the RT gene and HIV-l resistance to AZT was 
clearly demonstrated [6], the true biochemical basis of 
this phenomenon remains still obscure. KimP and K,“ZT-TP 
values for the w.t. RT and ‘complete’ mutant which was 
isolated from AZT resistant virus were shown to be the 
same when poly(rA) . oligo(dT) was used as a template 
[6]. To further investigate its properties, we obtained 
CM by an oligonucleotide-directed mutagenesis tech- 
nique and carried out experiments with ribo- and deox- 
yribonucleotide heteropolymer templates-primers 
(RNAtp and DNAtp-1). These templates had the same 
100 base-long nucleotide sequences immediately follow- 
ing the 3’-end of the primer. The first nucleotide to be 
incorporated into the growing DNA chain was dTMP. 
Table I gives the kinetic parameters for the w.t.RT and 
CM RT for dTTP. As seen from Table I, K,,, values 
differ only slightly. whereas I’,,,,, for CM is lowered by 
a factor of 1.510. The KimP value on poly(rA).oligo(dT) 
is close to that reported previously [6,15,16]. 
The K,,, values of the enzymes for several templates 
are listed in Table II. A clear-cut distinction between 
DNA and RNA templates is found: in the case of CM 
the values for RNA templates are significantly reduced 
whereas for DNAtp-1 they are close. The data pre- 
sented in Tables I and II suggest that mutations affect 
somehow the template binding whereas the dNTP bind- 
ing remains virtually unchanged. These results are in 
accordance with recent X-ray data [17] pointing to the 
Table II 
K,,, (nM) values for templates of the w.t. and CM reverse transcriptases 
RT Template-primer 
Poly(rA) dT,, RNAtp DNAtp-1 
w.t. 146.0 k 7.0 1.450.0 f 200 3.6 + 0.8 
CM 54.0 + 15.0 190.0 + 30 2.4 + 0.5 
The saturating concentrations of dNTPs (30 PM) were used. 
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fact that the mutations are located in the template bind- 
ing region of RT. 
Table III shows the results on inhibition of the w.t. 
and mutant RTs by AZT-TP. Inhibition of the w.t. RT 
was shown to be competitive versus dTTP [ 15,161. It can 
be seen from Table III that the K, values depend on the 
template used, and therefore the inhibition cannot be 
defined as a ‘pure competitive’. For RNAtp, the K, 
value of the mutant is increased by a factor of about ten 
pointing to the weakening of the AZT-TP affinity to the 
enzyme-template complex. 
Gel electrophoresis experiments were performed for 
further characterization of CM properties. Figs. 1 and 
2 illustrate the results for RNAtp and DNAtp-1, respec- 
tively. One can see that the mutant can elongate the 
primer on both RNA and DNA templates with an effi- 
ciency approximating that of the w.t. enzyme (Fig. lC, 
lanes 9, 10; Fig. 2C. lanes 1 and 2). The tests for proces- 
sivity of DNA synthesis also showed no pronounced 
distinctions between the w.t. RT and CM (data not 
shown). 
The primer extension experiments in the presence of 
AZT-TP revealed the marked distinction between the 
w.t. and mutant enzymes. AZT-TP used as the only 
substrate (i.e. in the absence of other dNTPs) was ade- 
quately incorporated into DNA chains in the RNA- 
directed synthesis catalyzed by both the w.t. and mutant 
RTs (Fig. IA). In contrast to this, CM was unable to 
incorporate AZT-MP in the range of concentrations 
from 0.005 to 50 PM when DNAtp-1 was used as a 
template-primer (Fig. 2A). A similar pattern was ob- 
Table III 
Inhibitton of the w.t. and CM reverse transcrtptases by AZT-TP 
RT Template-primer 
Poly(rA) dT,, RNAtp DNAtp-1 
w.t. 0.030 + 0.002 0 120 k 0.030 0.110 f 0 020 
CM 0.090 f 0.003 1.560 k 0.650 0.420 f 0.010 
K, @M) were calculated according to competitive mode of mhtbmon 
versus dTTP The saturating concentrattons of substrates were used. 
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Fig. 1. RNA-directed DNA synthesis by w.t. and CM RTs. 32P-labeled RNAtp (see section 2) was used as a template-primer. (A) Primer extension 
by the w.t. (lanes l-5) and CM (lanes 6-10) RTs in the presence of AZT-TP as the only substrate. AZT-TP concentrations @M): 0.005 (lanes 5. 
10); 0.05 (lanes 4. 9); 0.5 (lanes 3, 8); 5.0 (lanes 2, 7); 50.0 (lanes 1. 6). (B) Primer extension by the w.t. (lanes 14) and CM (lanes 5-8) RTs in the 
presence of AZT-TP and 25 PM each of dNTPs. AZT-TP concentrations @M): 0.05 (lanes 4, 8); 0.5 (lanes 3, 7); 5.0 (lanes 2, 6); 50.0 (lanes 1, 
5). (C) The fidelity of the DNA synthesis by the w.t. (odd lanes) and CM (even lanes) RTs. All samples contamed 25 PM of each dNTP except 
for the indicated. The positlons of primer and first four dNMPs to be incorporated are shown at the right margin. 
served in the presence of dNTPs with dTTP omitted 
(data not shown). No detectable termination by AZT- 
TP was observed in the DNA- but not RNA-directed 
synthesis when all four dNTPs were present (Figs. 1B 
and 2B). 
DNAtp-2 was used as an alternative DNA template- 
4-c 
Ij 4-G 
c +I CT 
c primer -Qua* +. primer 
12345678910 
w.t. CM. 
A C 
Fig. 2. DNA-directed DNA synthesis by w.t. and CM RTs. 32P-labeled DNAtp-1 (see section 2) was used as a template-primer. (A) Primer extension 
by the w.t. (lanes l-5) and CM (lanes 610) RTs in the presence of AZT-TP as the only substrate. AZT-TP concentrations @M): 0.005 (lanes 5, 
10); 0.05 (lanes 4. 9); 0.5 (lanes 3, 8); 5.0 (lanes 2, 7): 50.0 (lanes 1, 6). (B) Primer extension by the w.t. (lanes 14) and CM (lanes 5-8) RTs in the 
presence of AZT-TP and 25 PM each of dNTPs. AZT-TP concentrations @M): 0.05 (lanes 4, 8); 0.5 (lanes 3. 7); 5.0 (lanes 2, 6): 50.0 (lanes 1, 
5). (C) The fidelity of the DNA synthcsls. The lanes 1 (w.t.) and 2 (CM) are control of synthesis in the presence of all four dNTPs. From the third 
lane the samples contained either 12.5 PM (odd lanes) or 50 ,uM (even lanes) of each dNTP. except for the indicated. 
12345678 
WA, C.M. 
12345678~‘~~‘~1,31~~1~~ --uu 
w.t.CM w.l.CM w.l.CM w.t.CM 
I-‘(’ 
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w.t. CM. w.t. CM. 
Fig. 3. DNA-directed DNA synthesis by w.t. and CM RTs. “P-labeled 
DNAtp-2 (see section 2) was used as a templateeprimer. Primer exten- 
sion by w.t. (lanes 14) and CM (lanes 5%) RTs in the presence of 
AZT-TP and 25 PM each of dNTPs, when dTTP omitting. and in the 
presence of all dNTPs (lanes 9912 = w.t., lanes 13-16 = CM). AZT- 
TP concentrations MM), 0.05 (lanes 4, 8, 12. l6), 0.5 (lanes 3, 7. I I. 
15): 5.0 (lanes 2, 6, 10. 14); 50.0 (lanes I. 5. 9. 13). The strong stop on 
dCMP at position + I was observed for both the w.t. and CM. 
primer. In this case dTMP was the third nucleotide to 
be incorporated into the growing DNA chain (Fig. 3). 
When dTTP was omitted from the reaction mixture, 
only traces of AZT-MP incorporation by CM were de- 
tected. In the presence of all four dNTPs no detectable 
incorporation of azidonucleotide was demonstrated 
over the wide range of AZT-TP concentrations. 
It is noteworthy that the reduced capability of CM to 
use AZT-TP as a substrate is not connected with varia- 
tions in fidelity of DNA synthesis. As seen from the 
Figs. 1 C and 2C. no visible distinctions between the w.t. 
RT and CM in the DNA synthesis are detected when 
one of the four dNTPs is omitted. It is precisely the 
interactions of the enzyme with AZT-TP which are af- 
fected by the mutations. An indirect evidence in favour 
of this hypothesis is the sensitivity of AZT-resistant 
HIV- 1 isolates to an alternative ‘terminator-like’ drug, 
dideoxycytidine [IS]. 
The data obtained show that the mutations result in 
moderate decreases in the V,,, values with both RNA 
and DNA templates. Distinct changes of the template 
affinity were detected for heteropolymer RNA only. 
The AZT-TP affinity of CM was decreased, once again 
the effect being more pronounced when using the heter- 
opolymer RNA template. In this regard the latter is 
more suitable than a commonly used 
poly( rA) oligo(dT). 
It is evident that the mutations affect the template 
binding only (as X-ray data also suggest), whereas 
dNTP’s interactions remain practically unchanged. The 
mutations result in an increase in RT affinity to RNA 
template, whereas the DNA template affinity remains 
the same. Taking into account a large difference in the 
Km values for RNA and DNA templates of the same 
nucleotide sequences. one can suggest that some struc- 
tural distinctions between the w.t. RT complexes with 
RNA and DNA exist. It seems that the mutations con- 
tribute to these distinctions so that AZT-TP utilization 
by CM in RNA- and DNA-directed synthesis has con- 
siderable differences. In the latter case, the binding of 
AZT-TP in the dNTP site of the enzyme results in the 
formation of unproductive ES complex (this effect is 
more pronounced when dTMP is the first nucleotide to 
be incorporated) and reveals itself in the inhibitory ef- 
fect. 
Relying on the data obtained some considerations 
can be applied to the original rise of the HIV-1 resis- 
tance to AZT. According to current concept, both 
RNA- and DNA-directed DNA synthesis in HIV- 1 rep- 
lication is catalyzed by RT [19]. These stages are vari- 
ously affected by mutations. A more than ten-fold re- 
duction in the AZT-TP affinity of the mutant enzyme 
results in a drop in the chain termination during the 
course of the RNA-directed synthesis. In the second 
stage of replication (in the presence of all four dNTPs) 
no effective termination happens at all and therefore the 
production of complete DNA copies of the viral RNA, 
even if at a lower rate, is a distinct possibility. 
The data obtained suggest an association between RT 
mutations and changes m its enzymatic properties. 
However. it is not inconceivable that additional mecha- 
nisms are also involved in the total AZT therapeutic 
effect. 
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